These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27264216)

  • 1. Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation.
    Eckman MH; Lip GY; Wise RE; Speer B; Sullivan M; Walker N; Kissela B; Flaherty ML; Kleindorfer D; Baker P; Ireton R; Hoskins D; Harnett BM; Aguilar C; Leonard AC; Arduser L; Steen D; Costea A; Kues J
    Am Heart J; 2016 Jun; 176():17-27. PubMed ID: 27264216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age.
    Eckman MH; Lip GY; Wise RE; Speer B; Sullivan M; Walker N; Kissela B; Flaherty ML; Kleindorfer D; Baker P; Ireton R; Hoskins D; Harnett BM; Aguilar C; Leonard A; Arduser L; Steen D; Costea A; Kues J
    J Am Geriatr Soc; 2016 May; 64(5):1054-60. PubMed ID: 27225358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation decision support tool: Population perspective.
    Eckman MH; Costea A; Attari M; Munjal J; Wise RE; Knochelmann C; Flaherty ML; Baker P; Ireton R; Harnett BM; Leonard AC; Steen D; Rose A; Kues J
    Am Heart J; 2017 Dec; 194():49-60. PubMed ID: 29223435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.
    Guo Y; Lip GY; Apostolakis S
    Hosp Pract (1995); 2013 Feb; 41(1):71-8. PubMed ID: 23466969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.
    Lip GY; Clementy N; Pericart L; Banerjee A; Fauchier L
    Stroke; 2015 Jan; 46(1):143-50. PubMed ID: 25424474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of atrial fibrillation: recommendations from NICE.
    Lim WY; Khan F
    Br J Hosp Med (Lond); 2015 Jul; 76(7):C108-12. PubMed ID: 26140571
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic and anticoagulant therapy for atrial fibrillation.
    Dzeshka MS; Lip GY
    Cardiol Clin; 2014 Nov; 32(4):585-99. PubMed ID: 25443239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns and adherence to guidelines of antithrombotic therapy in Thai patients with nonvalvular atrial fibrillation.
    Jedsadayanmata A
    J Med Assoc Thai; 2013 Jan; 96(1):91-8. PubMed ID: 23720984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
    Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
    Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation practices in adults with congenital heart disease and atrial arrhythmias in Switzerland.
    Arslani K; Notz L; Zurek M; Greutmann M; Schwerzmann M; Bouchardy J; Engel R; Attenhofer Jost C; Tobler D;
    Congenit Heart Dis; 2018 Sep; 13(5):678-684. PubMed ID: 30033686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 13. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
    Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
    J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project.
    Angoulvant D; Villejoubert O; Bejan-Angoulvant T; Ivanes F; Saint Etienne C; Lip GYH; Fauchier L
    Chest; 2015 Aug; 148(2):491-498. PubMed ID: 25812113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
    O'Brien EC; Simon DN; Thomas LE; Hylek EM; Gersh BJ; Ansell JE; Kowey PR; Mahaffey KW; Chang P; Fonarow GC; Pencina MJ; Piccini JP; Peterson ED
    Eur Heart J; 2015 Dec; 36(46):3258-64. PubMed ID: 26424865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can a best practice advisory improve anticoagulation prescribing to reduce stroke risk in patients with atrial fibrillation?
    Eckman MH; Wise R; Knochelmann C; Mardis R; Leonard AC; Wright S; Gummadi A; Dixon E; Becker RC; Schauer DP; Flaherty ML; Costea A; Kleindorfer D; Ireton R; Baker P; Harnett BM; Adejare A; Sucharew H; Arduser L; Kues J
    J Cardiol; 2024 May; 83(5):285-290. PubMed ID: 37579873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
    Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic health record-embedded decision support to reduce stroke risk in patients with atrial fibrillation - Study protocol.
    Eckman MH; Wise R; Knochelmann C; Mardis R; Wright S; Gummadi A; Dixon E; Becker R; Schauer DP; Flaherty ML; Costea A; Kleindorfer D; Ireton R; Baker P; Harnett BM; Adejare A; Leonard AC; Sucharew H; Costanzo A; Arduser L; Kues J
    Am Heart J; 2022 May; 247():42-54. PubMed ID: 35081360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.